UPXI vs. ADMA

Last updated Jun 24, 2026

UPXI (Upexi Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. UPXI operates in Internet Content & Information (Communication Services), while ADMA operates in Biotechnology (Healthcare). Over the past 5 years, UPXI returned -62.46%/yr vs 39.41%/yr for ADMA. At a 0.11 correlation, their price movements are largely independent.

Performance

UPXI vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Upexi Inc. (UPXI) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with UPXI having a -50.30% return and ADMA slightly lower at -52.36%.

UPXI

• 1D: -3.47%
• 1M: -37.69%
• YTD: -50.30%
• 6M: -54.62%
• 1Y: -91.65%
• 3Y*: -73.94%
• 5Y*: -62.46%
• 10Y*: —

ADMA

• 1D: 1.40%
• 1M: 5.46%
• YTD: -52.36%
• 6M: -55.41%
• 1Y: -51.37%
• 3Y*: 30.95%
• 5Y*: 39.41%
• 10Y*: 2.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UPXI vs. ADMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
UPXI Upexi Inc.	-50.30%	-52.14%	-84.87%	-61.33%	-25.37%	-19.60%
ADMA ADMA Biologics, Inc.	-52.36%	6.36%	279.42%	16.49%	175.18%	-15.06%

Correlation

The correlation between UPXI and ADMA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021	0.11

Fundamentals

Market Cap UPXI : $54.70M ADMA : $2.09B
EPS UPXI : -$4.10 ADMA : $0.68
PS Ratio UPXI : 1.78 ADMA : 4.16
Total Revenue (TTM) UPXI : $26.14M ADMA : $509.86M
Gross Profit (TTM) UPXI : $22.60M ADMA : $312.42M
EBITDA (TTM) UPXI : -$52.70M ADMA : $218.74M

Return for Risk

UPXI vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UPXI

UPXI Risk / Return Rank: 10
UPXI Sharpe Ratio Rank: 16
UPXI Sortino Ratio Rank: 10
UPXI Omega Ratio Rank: 12
UPXI Calmar Ratio Rank: 2
UPXI Martin Ratio Rank: 10

ADMA

ADMA Risk / Return Rank: 7
ADMA Sharpe Ratio Rank: 6
ADMA Sortino Ratio Rank: 8
ADMA Omega Ratio Rank: 8
ADMA Calmar Ratio Rank: 11
ADMA Martin Ratio Rank: 4

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UPXI vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Upexi Inc. (UPXI) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UPXI	ADMA	Difference
Sharpe ratio: Return per unit of total volatility	-0.60	-0.95	+0.35
Sortino ratio: Return per unit of downside risk	-1.18	-1.30	+0.12
Omega ratio: Gain probability vs. loss probability	0.87	0.82	+0.04
Calmar ratio: Return relative to maximum drawdown	-0.98	-0.82	-0.16
Martin ratio: Return relative to average drawdown	-1.37	-1.64	+0.27

UPXI vs. ADMA - Sharpe Ratio Comparison

The current UPXI Sharpe Ratio is -0.60, which is higher than the ADMA Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of UPXI and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UPXI vs. ADMA - Drawdown Comparison

The maximum UPXI drawdown since its inception was -99.64%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for UPXI and ADMA.

Drawdown Indicators

	UPXI	ADMA	Difference
Max Drawdown Largest peak-to-trough decline	-99.64%	-91.28%	-8.36%
Max Drawdown (1Y) Largest decline over 1 year	-93.39%	-62.71%	-30.68%
Max Drawdown (3Y) Largest decline over 3 years	-98.85%	-68.99%	-29.86%
Max Drawdown (5Y) Largest decline over 5 years	-99.64%	-68.99%	-30.65%
Max Drawdown (10Y) Largest decline over 10 years	—	-86.11%	—
Current Drawdown Current decline from peak	-99.47%	-64.55%	-34.92%
Average Drawdown Average peak-to-trough decline	-72.96%	-53.07%	-19.89%
Ulcer Index Depth and duration of drawdowns from previous peaks	71.85%	31.44%	+40.41%

Volatility

UPXI vs. ADMA - Volatility Comparison

Upexi Inc. (UPXI) has a higher volatility of 26.13% compared to ADMA Biologics, Inc. (ADMA) at 10.26%. This indicates that UPXI's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UPXI	ADMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.13%	10.26%	+15.87%
Volatility (6M) Calculated over the trailing 6-month period	95.76%	45.76%	+50.00%
Volatility (1Y) Calculated over the trailing 1-year period	153.65%	54.14%	+99.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	203.38%	59.49%	+143.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	203.38%	69.07%	+134.31%

Dividends

UPXI vs. ADMA - Dividend Comparison

Neither UPXI nor ADMA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both UPXI and ADMA in my portfolio?

UPXI and ADMA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UPXI or ADMA?

UPXI has higher volatility (26.13%) compared to ADMA (10.26%). In terms of maximum drawdown, UPXI dropped -99.64% vs ADMA's -91.28%.

Which has better risk-adjusted returns?

UPXI currently has the higher Sharpe Ratio (-0.60 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.